首页> 外国专利> Method for treating the facial paralysis

Method for treating the facial paralysis

机译:治疗面瘫的方法

摘要

The invention refers to medicine, neurology, pediatrics and is meant for treating the facial paralysis of newborn babies, infants, children and grown-ups.The method, according to the invention, consists in that there are administered per os the preparations Bryaconeel and Engystol N ¼...1 tablet, Lymphomyosot and Galium-Heel 3...10 drops during 1 month 3 times a day and subcutaneously the preparations TraumeelS 0,3...2,2 ml daily in the first 3 days, then within 1 day, Cerebrum compositum N 0,3...2,2 ml daily in the first 2 days, then within 2 days, Gelsemium-Homaccord 0,3...1,1 ml daily in the first 3 days, then within 2 days, Aconitum-Homaccord 0,3...1,1 ml daily in the first 3 days, then within 2 days, Echinacea compositum S 0,3...2,2 ml 2 times a week, to a treatment course of 7...10 injections, as well as Coenzyme compositum and Ubichinon compositum 0,3...2,2 ml once a week, to a treatment course of 2...4 injections. At the same time, the above-mentioned preparations are administered in the following biologically active points: E1, 2, 3, 4, 6, 7, 8, 36, 44; V1, 2, 3, 10, 11, 60; VB1, 3 14, 20, 21, 34, 39; TR23; IG18; GI19, 20; T14, 26, 27; G14, 10, 11; AP 11, 14, 33, 35, 37; J24; P7; RP6. Into each biologically active point it is introduced only a single medicinal preparation, which is administered 0,1...0,4 ml in 3...5 points, at the same time every day there are selected different biologically active points.
机译:本发明涉及医学,神经病学,小儿科,并且用于治疗新生婴儿,婴儿,儿童和成年人的面部瘫痪。根据本发明的方法在于,所述的方法是给人服用布里亚酮和恩吉斯托尔的制剂。 N¼... 1片,Lymphomyosot和Galium-Heel 3 ... 10滴,在1个月内每天3次,并在头3天每天皮下制备TraumeelS 0,3 ... 2,2 ml,然后在1天,头2天每天服用脑复合物N 0,3 ... 2,2 ml,然后在2天内,头3天每天服用Gelsemium-Homaccord 0,3 ... 1,1 ml,然后前2天每天2天,头3天每天服用0,3 ... 1,1 ml乌头,然后在2天之内,每周2次服用紫锥菊(Echinacea compositum)S 0,3 ... 2,2 ml,共2次,疗程每周一次,每次7 ... 10针,以及辅酶compositum和Ubichinon compositum 0,3 ... 2,2 ml,至2 ... 4针的疗程。同时,上述制剂以下列生物活性点给药:E1、2、3、4、6、7、8、36、44; E1、2、3、4、6、7、8、36、44; E1、2、3、4、6、7、8、36、44。 V1、2、3、10、11、60; VB1、3 14、20、21、34、39; TR23; IG18; GI19,20; T14、26、27; G14、10、11; AP 11,14,33,35,37; J24; P7; RP6。在每个生物活性点中仅引入一种药物制剂,该药物以3 ... 5个点给药0.1,... 0.4毫升,每天同时选择不同的生物活性点。

著录项

  • 公开/公告号MD3927G2

    专利类型

  • 公开/公告日2010-01-31

    原文格式PDF

  • 申请/专利权人 HADJIU SVETLANA;

    申请/专利号MD20080000102

  • 发明设计人 HADJIU SVETLANA;

    申请日2008-04-07

  • 分类号A61K35/00;A61K35/12;A61K35/30;A61K35/32;A61K35/407;A61P21/00;A61P25/02;

  • 国家 MD

  • 入库时间 2022-08-21 18:45:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号